EUVIMEDEUVIMED entdecken
Open Access

Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis

Laura J Mereweather, Daniel Harwood iD, Josefin Ahnström iD, Joseph van Batenburg-Sherwood iD, Isabelle I Salles-Crawley iD, James T B Crawley iD

Science Advances · 07.02.2025 · 11 (6)

DOI: 10.1126/sciadv.adr5250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 07.02.2025. Verfasst von Laura J Mereweather und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Haematology, Department of Immunology and Inflammation, Hammersmith Hospital Campus, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Venous Thrombosis, von Willebrand Factor, Blood Platelets. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deep vein thrombosis is a major cause of morbidity and mortality worldwide. However, because of the absence of overt blood vessel damage, how venous thrombosis is actually initiated remains unclear. Using endothelialized fluidic devices, we show that aberrant flow patterns that may occur in venous valve pockets of individuals with common stasis-related risk factors can cause the formation of von Willebrand factor–platelet tangles that are resistant to ADAMTS13 removal. These von Willebrand factor–bound platelets specifically recruit neutrophils in a manner that is dependent on platelet-activated α IIb β 3 , neutrophil SLC44A2, and endothelial P-selectin. The interaction of SLC44A2 with activated α IIb β 3 promotes formation of prothrombotic neutrophil extracellular traps. These data provide molecular and cellular insights into the proclivity for venous thrombosis to develop in venous valve pockets and suggest an alternative strategy to protect against the initiation of venous thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous Thrombosisvon Willebrand FactorBlood PlateletsHumansNeutrophilsExtracellular TrapsADAMTS13 ProteinPlatelet Glycoprotein GPIIb-IIIa ComplexPlatelet ActivationP-Selectin

Substanzen

von Willebrand FactorADAMTS13 ProteinPlatelet Glycoprotein GPIIb-IIIa ComplexP-SelectinADAMTS13 protein, human

Autor:innen und Institutionen

  • Centre for Haematology, Department of Immunology and Inflammation, Hammersmith Hospital Campus, Imperial College London, London, UK.
  • Department of Bioengineering, White City Campus, Imperial College London, London, UK.
  • Cardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London, UK.

ORCID-Profile: Daniel Harwood, Josefin Ahnström, Joseph van Batenburg-Sherwood, Isabelle I Salles-Crawley, James T B Crawley

Zitieren

APA

Mereweather, L. J., Harwood, D., Ahnström, J., van Batenburg-Sherwood, J., Salles-Crawley, I. I., & Crawley, J. T. B. (2025). Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis. Science Advances, 11(6). https://doi.org/10.1126/sciadv.adr5250

Vancouver

Mereweather LJ, Harwood D, Ahnström J, van Batenburg-Sherwood J, Salles-Crawley II, Crawley JTB. Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis. Science Advances. 2025;11(6). doi:10.1126/sciadv.adr5250

BibTeX
@article{Mereweather2025,
  author = {Mereweather, Laura J and Harwood, Daniel and Ahnström, Josefin and van Batenburg-Sherwood, Joseph and Salles-Crawley, Isabelle I and Crawley, James T B},
  title = {Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {6},
  doi = {10.1126/sciadv.adr5250}
}
Kostenlos starten →